Línea Directa Aseguradora Compañía de Seguros y Reaseguros walked into this Q3 2026 earnings release with a tired chart and a sceptical audience. The share price closed at €1.192 on 30 October, with the stock drifting lower over 7, 30 and 90 days. Yet the headline story is very different from the mood. Insurance revenue reached €345.445m and net income came in at €28.32m, supported by a combined ratio for the year to date that management flagged at 91.3%. Short term price fatigue is colliding with improving profitability.
Interested in Línea Directa Aseguradora Compañía de Seguros y Reaseguros’ improving profitability but wary of a chart that still looks heavy? Compare this setup with our screener of financially robust insurers and other businesses in the list of solid balance sheet and fundamentals stocks (202 results).
Profits jumped as Línea Directa grew faster than the market. Ask Charlie what keeps Línea Directa’s combined ratio near 91%.
"Analysts expect Línea Directa Aseguradora Compañía de Seguros y Reaseguros to continue using digitalization, automation and analytics to improve its expense ratio and underwriting results, with the aim of growing premiums faster than the wider non life market."
Línea Directa is putting numbers behind that ambition. Gross written premiums reached €919m for 9M 2026, with the policy count up 6.9% to 3.9m. The combined ratio sits at 91.3% and the expense ratio has moved to 20%. Motor premiums are €750m with 212,000 policies added in the year to date. Health and Home both show premium growth and improving technical performance. These are concrete milestones for a thesis built on profitable scale rather than just volume.
"The Health insurance business, which still reports a combined ratio of 125.1% despite recent improvement, may take longer than expected to reach breakeven. This would continue to dilute group underwriting results and put pressure on net margins and earnings."
The latest Health numbers still back part of that worry but with more nuance. Premiums in Health grew 17% to €35.7m and customers reached 131,000, with higher coverage products now 68.2% of the mix. The combined ratio for Health in Q3 is 122.3%. That remains loss making, but the direction supports the idea of gradual repair rather than escalating drag, especially with the group combined ratio at 91.3% and Solvency II at 191.5% giving Línea Directa room to absorb the shortfall.
The price and this Narrative do not agree. → Uncover what this Narrative says Línea Directa Aseguradora Compañía de Seguros y Reaseguros is actually worth.
Línea Directa Aseguradora Compañía de Seguros y Reaseguros has paired a softer share price with improving underwriting metrics and earnings. The real opportunity is finding stocks that could be undervalued before the market corrects them.
Three companies from the same screener. Open every one of the 201 undervalued companies on it →
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com